Greenstatin

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameGreenstatin
Drug Alias NameRecombinant human apolipoprotein (a) Kringle VRecombinant anti-angiogenic proteinMG-1102rhLK8
ClassificationBiologics > Protein drugs > Recombinant proteinCell and gene therapy > Gene therapy
Mechanisms of ActionAngiogenesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGC Biopharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGC Biopharma Corp
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A